9-valent Human Papillomavirus Recombinant Vaccine

HPV9 vaccine · Shanghai Bovax Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 9-valent Human Papillomavirus Recombinant Vaccine, covering 2024-04-17 to 2024-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years [Phase 3]

See pricing